
Hwa S. Lee
Examiner (ID: 4021, Phone: (571)272-2419 , Office: P/2886 )
| Most Active Art Unit | 2877 |
| Art Unit(s) | 2886, 2877 |
| Total Applications | 1588 |
| Issued Applications | 1141 |
| Pending Applications | 193 |
| Abandoned Applications | 271 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18201150
[patent_doc_number] => 11583521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Long-acting injection dosage form of beta 3 adrenoreceptor agonists
[patent_app_type] => utility
[patent_app_number] => 17/364469
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10577
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364469 | Long-acting injection dosage form of beta 3 adrenoreceptor agonists | Jun 29, 2021 | Issued |
Array
(
[id] => 17503405
[patent_doc_number] => 20220096507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO
[patent_app_type] => utility
[patent_app_number] => 17/423210
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423210 | Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO | Jun 28, 2021 | Abandoned |
Array
(
[id] => 17168625
[patent_doc_number] => 20210322295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Cleansing Compositions
[patent_app_type] => utility
[patent_app_number] => 17/304578
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304578 | Cleansing compositions | Jun 22, 2021 | Issued |
Array
(
[id] => 17124399
[patent_doc_number] => 20210299167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/346615
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346615 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | Jun 13, 2021 | Pending |
Array
(
[id] => 19608070
[patent_doc_number] => 12156929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Topical antimicrobial composition
[patent_app_type] => utility
[patent_app_number] => 17/926267
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6214
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926267 | Topical antimicrobial composition | Jun 7, 2021 | Issued |
Array
(
[id] => 17312661
[patent_doc_number] => 20210401709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/340594
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340594 | PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS | Jun 6, 2021 | Abandoned |
Array
(
[id] => 17241944
[patent_doc_number] => 20210361687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => COMBINATION PRODUCTS OF TOBRAMYCIN COMPOUNDS AND DEXAMETHASONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/327703
[patent_app_country] => US
[patent_app_date] => 2021-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327703 | Combination products of tobramycin compounds and dexameihasone compounds | May 21, 2021 | Issued |
Array
(
[id] => 18434150
[patent_doc_number] => 20230181444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS COMPRISING ORGANO-SILANOL COMPOUNDS, AND APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/999321
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999321 | Compositions comprising organo-silanol compounds, and applications | May 19, 2021 | Issued |
Array
(
[id] => 19960263
[patent_doc_number] => 12329735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Azelaic acid esters in the treatment of insulin resistance
[patent_app_type] => utility
[patent_app_number] => 17/318586
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2439
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318586 | Azelaic acid esters in the treatment of insulin resistance | May 11, 2021 | Issued |
Array
(
[id] => 20341933
[patent_doc_number] => 12465649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer
[patent_app_type] => utility
[patent_app_number] => 17/315962
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 325
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315962 | Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer | May 9, 2021 | Issued |
Array
(
[id] => 17539847
[patent_doc_number] => 11304951
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-19
[patent_title] => Dosing regimens associated with extended release paliperidone injectable formulations
[patent_app_type] => utility
[patent_app_number] => 17/314330
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17063
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314330 | Dosing regimens associated with extended release paliperidone injectable formulations | May 6, 2021 | Issued |
Array
(
[id] => 18391746
[patent_doc_number] => 20230159964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHOD TO PRODUCE BIOCATALYTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/997724
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997724 | METHOD TO PRODUCE BIOCATALYTICAL COMPOSITIONS | May 5, 2021 | Pending |
Array
(
[id] => 16990121
[patent_doc_number] => 20210228541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 17/231761
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231761 | FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18724159
[patent_doc_number] => 20230338279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS
[patent_app_type] => utility
[patent_app_number] => 17/918790
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918790 | NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS | Apr 12, 2021 | Pending |
Array
(
[id] => 17198502
[patent_doc_number] => 20210338596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => ANTIBACTERIAL NANOFIBER
[patent_app_type] => utility
[patent_app_number] => 17/227940
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227940 | Antibacterial nanofiber | Apr 11, 2021 | Issued |
Array
(
[id] => 16930944
[patent_doc_number] => 20210196833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => PACLITAXEL-HYALURONIC ACID CONJUGATE IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/204183
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204183 | PACLITAXEL-HYALURONIC ACID CONJUGATE IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER | Mar 16, 2021 | Abandoned |
Array
(
[id] => 19279116
[patent_doc_number] => 20240215587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => COMPOSITION FOR PREVENTING AND TREATING BACTERIAL LEAF STREAK OF RICE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/548989
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548989 | COMPOSITION FOR PREVENTING AND TREATING BACTERIAL LEAF STREAK OF RICE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Mar 8, 2021 | Pending |
Array
(
[id] => 17183847
[patent_doc_number] => 20210330732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHOD OF MAKING SOLANACEAE FRUIT EXTRACTS
[patent_app_type] => utility
[patent_app_number] => 17/192155
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192155 | METHOD OF MAKING SOLANACEAE FRUIT EXTRACTS | Mar 3, 2021 | Abandoned |
Array
(
[id] => 16930784
[patent_doc_number] => 20210196673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING RESPIRATORY VIRAL INFECTIONS USING GREEN TREE EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/182425
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15197
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182425 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING RESPIRATORY VIRAL INFECTIONS USING GREEN TREE EXTRACT | Feb 22, 2021 | Abandoned |
Array
(
[id] => 18256378
[patent_doc_number] => 20230083417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA
[patent_app_type] => utility
[patent_app_number] => 17/797450
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/797450 | THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA | Feb 18, 2021 | Pending |